首页 > 最新文献

Arterial Hypertension最新文献

英文 中文
Latest findings on labetalol in severe hypertension during pregnancy and in postpartum — a systematic review 拉贝洛尔治疗妊娠期和产后严重高血压的最新研究成果 - 系统综述
IF 0.7 Q4 Medicine Pub Date : 2023-12-29 DOI: 10.5603/ah.97679
Maciej Makarewicz, Jarosław D. Kasprzak, J. Peruga
{"title":"Latest findings on labetalol in severe hypertension during pregnancy and in postpartum — a systematic review","authors":"Maciej Makarewicz, Jarosław D. Kasprzak, J. Peruga","doi":"10.5603/ah.97679","DOIUrl":"https://doi.org/10.5603/ah.97679","url":null,"abstract":"","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139144154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Photoplethysmography technology use in smart devices for early diagnosis of arterial hypertension: a systematic review 智能设备中用于早期诊断动脉高血压的光电血压计技术:系统综述
IF 0.7 Q4 Medicine Pub Date : 2023-12-12 DOI: 10.5603/ah.94874
Simona Andriekutė, Kamilė Bagdonaitė, Mažvydas Savickas, Kristina Ziutelienė
{"title":"Photoplethysmography technology use in smart devices for early diagnosis of arterial hypertension: a systematic review","authors":"Simona Andriekutė, Kamilė Bagdonaitė, Mažvydas Savickas, Kristina Ziutelienė","doi":"10.5603/ah.94874","DOIUrl":"https://doi.org/10.5603/ah.94874","url":null,"abstract":"","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139007159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ventricular–arterial coupling indices reflects early stage of left ventricular remodelling in atrial fibrillation 心室-动脉耦合指数反映心房颤动左心室重塑的早期阶段
IF 0.7 Q4 Medicine Pub Date : 2023-11-14 DOI: 10.5603/ah.97127
M. Gaczoł, A. Olszanecka, K. Stolarz-Skrzypek, Marek Rajzer, W. Wojciechowska
{"title":"Ventricular–arterial coupling indices reflects early stage of left ventricular remodelling in atrial fibrillation","authors":"M. Gaczoł, A. Olszanecka, K. Stolarz-Skrzypek, Marek Rajzer, W. Wojciechowska","doi":"10.5603/ah.97127","DOIUrl":"https://doi.org/10.5603/ah.97127","url":null,"abstract":"","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139276295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The overall echogenicity (GSM) of carotid intima-media complex shows a positive correlation with arterial stiffness in hypertensive patients 高血压患者颈动脉内膜-中膜复合体的整体回声(GSM)与动脉僵化呈正相关关系
IF 0.7 Q4 Medicine Pub Date : 2023-11-14 DOI: 10.5603/ah.96896
Francesco Natale, S. Covino, R. Molinari, M. Limatola, N. Mollo, R. Alfieri, E. Pezzullo, F. Loffredo, Paolo Golino, G. Cimmino
{"title":"The overall echogenicity (GSM) of carotid intima-media complex shows a positive correlation with arterial stiffness in hypertensive patients","authors":"Francesco Natale, S. Covino, R. Molinari, M. Limatola, N. Mollo, R. Alfieri, E. Pezzullo, F. Loffredo, Paolo Golino, G. Cimmino","doi":"10.5603/ah.96896","DOIUrl":"https://doi.org/10.5603/ah.96896","url":null,"abstract":"","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139277780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ischemic stroke and hypertension in a child — a case report of two patients 儿童缺血性中风和高血压--两名患者的病例报告
IF 0.7 Q4 Medicine Pub Date : 2023-09-30 DOI: 10.5603/ah.a2023.0017
Jan Koziej, Krzysztof Skoczyński, Michał Pac, Łukasz Obrycki, M. Litwin
{"title":"Ischemic stroke and hypertension in a child — a case report of two patients","authors":"Jan Koziej, Krzysztof Skoczyński, Michał Pac, Łukasz Obrycki, M. Litwin","doi":"10.5603/ah.a2023.0017","DOIUrl":"https://doi.org/10.5603/ah.a2023.0017","url":null,"abstract":"","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139332412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of alpha-adrenergic receptor antagonists use on outcomes in patients with heart failure. A post-hoc analysis using Polish National Health Fund database 使用α-肾上腺素能受体拮抗剂对心力衰竭患者预后的影响。利用波兰国家卫生基金数据库进行的事后分析
IF 0.7 Q4 Medicine Pub Date : 2023-09-30 DOI: 10.5603/ah.97054
B. Symonides, Jacek Lewandowski, Andrzej Śliwczyński
hyper-Abstract Background: The alpha-adrenolytics (AA) are not recommended in patients with ejection fraction (EF) reduced heart failure due to safety concerns. The aim of our study was to assess the safety of AA in patients hospitalized due to exacerbation of HF and the influence of these drugs on long-term endpoints. Material and methods: Data collected by the National Health Fund tracking all patient admissions and taking of the drug prescriptions throughout the entire country was used. Patients hospitalized due to HF exacerbation were included. The primary outcome variable was all-cause mortality and the secondary was the first readmission due to HF or all-cause death occurring more than 30 days after discharge. Results: Of 140 668 patients hospitalized in the year 2013, 53 317 were included and followed for a median of 56.3 months. AA patients had lower long-term all-cause mortality (52.8% vs . 54.9%, unadjusted p = 0.038). The treat-ment with AA positively and independently affected long-term survival [adjusted hazard ratio (adjHR): 0.82, 95% confidence interval (CI): 0.78–0.87, p < 0.001], as well as secondary endpoint (adjHR: 0.85, 95% CI: 0.81–0.90, p < 0.001). Cox analysis in the subgroup treated with beta-blockers revealed that treatment with AA was associated with lower mortality (adjHR: 0.82, 95% CI: 0.75–0.90, p < 0.001) and lower incidence of secondary endpoint (adjHR: 0.85, 95% CI: 0.78–0.92, p < 0.001). Conclusion: In compliant patients hospitalized due to HF exacerbation post discharge treatment with AA was safe and beneficial.
超摘要 背景:由于安全性问题,射血分数(EF)降低的心衰患者不推荐使用α-肾上腺素类药物(AA)。我们的研究旨在评估因心衰加重而住院的患者使用 AA 的安全性,以及这些药物对长期终点的影响。材料和方法:使用国家卫生基金收集的数据,这些数据追踪了全国所有患者的入院情况和药物处方的服用情况。其中包括因高血压恶化而住院的患者。主要结果变量为全因死亡率,次要结果变量为出院后 30 天内首次因高血压再次入院或全因死亡。研究结果在 2013 年住院的 140 668 名患者中,有 53 317 人接受了中位数为 56.3 个月的随访。AA患者的长期全因死亡率较低(52.8% 对 54.9%,未调整 p = 0.038)。AA治疗对长期生存期[调整后危险比(adjHR):0.82,95% 置信区间(CI):0.78-0.87,p < 0.001]和次要终点(adjHR:0.85,95% CI:0.81-0.90,p < 0.001)均有独立的积极影响。对使用β-受体阻滞剂治疗的亚组进行的Cox分析显示,使用AA治疗与较低的死亡率(adjHR:0.82,95% CI:0.75-0.90,p<0.001)和较低的次要终点发生率(adjHR:0.85,95% CI:0.78-0.92,p<0.001)相关。结论对于因心房颤动加重而住院的合规患者,出院后使用 AA 治疗是安全有益的。
{"title":"Impact of alpha-adrenergic receptor antagonists use on outcomes in patients with heart failure. A post-hoc analysis using Polish National Health Fund database","authors":"B. Symonides, Jacek Lewandowski, Andrzej Śliwczyński","doi":"10.5603/ah.97054","DOIUrl":"https://doi.org/10.5603/ah.97054","url":null,"abstract":"hyper-Abstract Background: The alpha-adrenolytics (AA) are not recommended in patients with ejection fraction (EF) reduced heart failure due to safety concerns. The aim of our study was to assess the safety of AA in patients hospitalized due to exacerbation of HF and the influence of these drugs on long-term endpoints. Material and methods: Data collected by the National Health Fund tracking all patient admissions and taking of the drug prescriptions throughout the entire country was used. Patients hospitalized due to HF exacerbation were included. The primary outcome variable was all-cause mortality and the secondary was the first readmission due to HF or all-cause death occurring more than 30 days after discharge. Results: Of 140 668 patients hospitalized in the year 2013, 53 317 were included and followed for a median of 56.3 months. AA patients had lower long-term all-cause mortality (52.8% vs . 54.9%, unadjusted p = 0.038). The treat-ment with AA positively and independently affected long-term survival [adjusted hazard ratio (adjHR): 0.82, 95% confidence interval (CI): 0.78–0.87, p < 0.001], as well as secondary endpoint (adjHR: 0.85, 95% CI: 0.81–0.90, p < 0.001). Cox analysis in the subgroup treated with beta-blockers revealed that treatment with AA was associated with lower mortality (adjHR: 0.82, 95% CI: 0.75–0.90, p < 0.001) and lower incidence of secondary endpoint (adjHR: 0.85, 95% CI: 0.78–0.92, p < 0.001). Conclusion: In compliant patients hospitalized due to HF exacerbation post discharge treatment with AA was safe and beneficial.","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139332658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practical use of single pill combinations in the treatment of hypertension — an analysis focused on perindopril-based combinations 单片复方制剂在高血压治疗中的实际应用--以培哚普利为基础的复方制剂分析
IF 0.7 Q4 Medicine Pub Date : 2023-09-30 DOI: 10.5603/ah.96726
A. Prejbisz, P. Dobrowolski, Adrian Doroszko, Krzysztof J Filipiak, Andrzej Januszewicz, A. Olszanecka, Krzysztof Narkiewicz, A. Tykarski, Jacek Wolf
{"title":"Practical use of single pill combinations in the treatment of hypertension — an analysis focused on perindopril-based combinations","authors":"A. Prejbisz, P. Dobrowolski, Adrian Doroszko, Krzysztof J Filipiak, Andrzej Januszewicz, A. Olszanecka, Krzysztof Narkiewicz, A. Tykarski, Jacek Wolf","doi":"10.5603/ah.96726","DOIUrl":"https://doi.org/10.5603/ah.96726","url":null,"abstract":"","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139332449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why some treated patients with arterial hypertension do not report of having it: Findings from epidemiological studies 为什么一些接受治疗的动脉高血压患者没有报告自己患有高血压?流行病学研究结果
IF 0.7 Q4 Medicine Pub Date : 2023-09-30 DOI: 10.5603/ah.a2023.0013
Piotr S. Szczęsny, Kacper Jagiełło, Krzysztof Flis, Tomasz Zdrojewski
{"title":"Why some treated patients with arterial hypertension do not report of having it: Findings from epidemiological studies","authors":"Piotr S. Szczęsny, Kacper Jagiełło, Krzysztof Flis, Tomasz Zdrojewski","doi":"10.5603/ah.a2023.0013","DOIUrl":"https://doi.org/10.5603/ah.a2023.0013","url":null,"abstract":"","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139333635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adrenal venous sampling as a method of primary hyperaldosteronism assessment 肾上腺静脉采样作为原发性醛固酮增多症的一种评估方法
IF 0.7 Q4 Medicine Pub Date : 2023-09-30 DOI: 10.5603/ah.96381
Ugo Giordano, Jakub Kobiałka
{"title":"Adrenal venous sampling as a method of primary hyperaldosteronism assessment","authors":"Ugo Giordano, Jakub Kobiałka","doi":"10.5603/ah.96381","DOIUrl":"https://doi.org/10.5603/ah.96381","url":null,"abstract":"","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139332736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood pressure control in tertiary-care hypertensive patients during COVID-19 pandemic COVID-19 大流行期间三级医院高血压患者的血压控制情况
IF 0.7 Q4 Medicine Pub Date : 2023-09-30 DOI: 10.5603/ah.97622
J. Wolf, Anna Nieckarz, Anna Panfil, Aleksandra Białas, Julia Sternicka, Łukasz Jędrzejewski, Michał Hoffmann, A. Szyndler, Aleksander Prejbisz, Michel Burnier, Krzysztof Narkiewicz
{"title":"Blood pressure control in tertiary-care hypertensive patients during COVID-19 pandemic","authors":"J. Wolf, Anna Nieckarz, Anna Panfil, Aleksandra Białas, Julia Sternicka, Łukasz Jędrzejewski, Michał Hoffmann, A. Szyndler, Aleksander Prejbisz, Michel Burnier, Krzysztof Narkiewicz","doi":"10.5603/ah.97622","DOIUrl":"https://doi.org/10.5603/ah.97622","url":null,"abstract":"","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139333456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arterial Hypertension
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1